Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 01-09-2014, 09:23 PM #1
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default Gene Therapy May Hold Promise for Advanced Parkinson's Disease

A new, preliminary treatment involving triple-gene therapy appears safe and effective in helping to control motor function in Parkinson's disease patients, according to new research.

The therapy, called ProSavin, works by reprogramming brain cells to produce dopamine, the chemical essential for controlling movement, the researchers said. Lack of dopamine causes the tremors, limb stiffness and loss of balance that patients with the neurodegenerative disease suffer.
Read more at

ProSavin also helps to smooth out the peaks and valleys often produced by the drug levodopa, the current standard treatment, Mitrophanous said.
Read more at

The treatment uses a harmless virus to deliver three dopamine-making genes directly to the area of the brain that controls movement, he explained. These genes are able to convert non-dopamine-producing nerve cells into dopamine-producing cells.

The researchers don't say new this therapy is a cure, because brain cells continue to die. "But the hope is that we would give patients an additional five years before the disease progresses further," Mitrophanous said.

"If you imagine you get five to 10 years of good control of symptoms with levodopa, we hope we would lengthen that. An extra five years, maybe longer, would be a real benefit to these patients," Mitrophanous said.

All patients showed significant improvements in motor scores in the 12 hours after they stopped taking their other medications and at six months and a year after surgery, the researchers found.

http://www.philly.com/philly/health/...s_Disease.html
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (01-09-2014), Aunt Bean (01-10-2014), chrishageseth (01-13-2014), Drevy (01-10-2014), lab rat (01-14-2014), olsen (01-12-2014), shcg (01-13-2014), soccertese (01-10-2014), Stand Tall (01-10-2014), StaveFoundation (01-20-2014)

advertisement
Old 01-10-2014, 07:36 AM #2
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default Building on this ...

See

http://www.oxfordbiomedica.co.uk/pre...in-the-lancet/

For a recent publication re. Prosavin in the lancet.

Neil
aftermathman is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
GerryW (01-10-2014), soccertese (01-10-2014), Stand Tall (01-10-2014)
Old 01-10-2014, 03:30 PM #3
Thelma's Avatar
Thelma Thelma is offline
Member
 
Join Date: Aug 2006
Location: Burnaby British Columbia
Posts: 795
15 yr Member
Thelma Thelma is offline
Member
Thelma's Avatar
 
Join Date: Aug 2006
Location: Burnaby British Columbia
Posts: 795
15 yr Member
Default sorry didn't see this

http://www.thelancet.com/journals/la...elsca3=E24A35F
Thelma is offline   Reply With QuoteReply With Quote
Old 01-11-2014, 12:09 AM #4
badboy99 badboy99 is offline
Member
 
Join Date: Aug 2012
Location: On a shiny blue dot
Posts: 626
10 yr Member
badboy99 badboy99 is offline
Member
 
Join Date: Aug 2012
Location: On a shiny blue dot
Posts: 626
10 yr Member
Default Wtf

Estimated Enrollment: 15
Study Start Date: May 2011
Estimated Study Completion Date: May 2022
Estimated Primary Completion Date: May 2021 (Final data collection date for primary outcome measure)

http://clinicaltrials.gov/show/NCT01856439
badboy99 is offline   Reply With QuoteReply With Quote
Old 01-11-2014, 03:49 AM #5
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default

You've got something with encouraging results, something that could improve the lives of millions of people with Parkinson's. You would think that you'd try to get it to market as soon as possible. How naive of me.

Look at OxfordBioMedica's press release dated 10th January 2014

http://www.oxfordbiomedica.co.uk/pre...in-the-lancet/

Look at the "Next objectives" section:

"Oxford BioMedica is currently evaluating a more potent formulation of ProSavin®, called OXB-102, to ensure the greatest chance of success in future randomised studies. OXB-102 will also increase the commercial opportunity by offering extended patent protection and a relative reduction in cost of goods."

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
Old 01-11-2014, 11:33 AM #6
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by johnt View Post
You've got something with encouraging results, something that could improve the lives of millions of people with Parkinson's. You would think that you'd try to get it to market as soon as possible. How naive of me.

John
Unfortunately, the reality is that a drug company's primary objective is profits. Patient symptom control and disease cure is only a secondary objective.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
olsen (01-12-2014)
Old 01-11-2014, 06:37 PM #7
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default I have been ...

Following prosavin for some time and it has a number of problems getting to market.

I) does it work ? What with the dreaded Placebo effect, the PD subtypes and our old friend "we all have our own blend of PD", this can be tough to prove.
Ii) is it better than the current best ? for prosavin this is DBS which has impressive stats for motor control at least. It takes no account of the risk and ordeal of fitting the DBS however DBS remains a tough act to beat (step forward neurologix to prove this point).
Iii) can I afford to take it to market ? Oxfordbiomedica have been trying to partner with big pharma for prosavin for years however the risk of gene therapy has proven a significant hurdle to date as well as the risk of the placebo effect, DBS, etc.

I have no doubt oxbio want to get prosavin to market, they get wealth unimagined if they can however their problems are not unique. Until we can get products to market at faster than geological time we will continue with a 40 year old drug, ldopa, or the trial of DBS.

As Mjf said a while ago, until we get a person in charge of curing PD then we are fighting with one arm only.

Take care,
Neil.
aftermathman is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (01-14-2014), olsen (01-12-2014), soccertese (01-12-2014)
Old 01-11-2014, 07:35 PM #8
lurkingforacure lurkingforacure is offline
Senior Member
 
Join Date: Feb 2008
Posts: 1,485
15 yr Member
lurkingforacure lurkingforacure is offline
Senior Member
 
Join Date: Feb 2008
Posts: 1,485
15 yr Member
Default same

Quote:
Originally Posted by badboy99 View Post
Estimated Enrollment: 15
Study Start Date: May 2011
Estimated Study Completion Date: May 2022
Estimated Primary Completion Date: May 2021 (Final data collection date for primary outcome measure)

http://clinicaltrials.gov/show/NCT01856439
And they wonder why they can't get people to participate in trials
lurkingforacure is offline   Reply With QuoteReply With Quote
Old 01-11-2014, 10:29 PM #9
girija girija is offline
Member
 
Join Date: Nov 2006
Location: southern tip of west coast
Posts: 582
15 yr Member
girija girija is offline
Member
 
Join Date: Nov 2006
Location: southern tip of west coast
Posts: 582
15 yr Member
Default reasons for a long term study

Oxfordbiomedica have been trying to partner with big pharma for prosavin for years however the risk of gene therapy has proven a significant hurdle to date as well as the risk of the placebo effect, DBS, etc.

Yes, the risk of gene therapy is a major hurdle for Prosavin. It is a lentiviral based gene therapy. Lentiviral vectors integrate into host DNA and are expressed like any host gene. I donot think Prosavin is any different than the conventional lenti viral vectors. This means, once Prosavin is injected into a patient, genes of interest and the viral vector are a part of patients DNA in cells it gets into.

This is both good and bad news. If it works, you will have all the enzymes you need to make dopamine forever and can be considered a cure.

The uncertain part is that we dont know the long term effects of a viral DNA inserted into your own DNA in neuronal cells. There is no way to pull it out if something goes wrong. If I remember correctly, several years ago, a few patients treated with mouse version of an integrating virus (muLV) created some problems, (I cannot recall all the details, sorry.)>I am sure Oxford Biomedica is aware of this, and probably one of the reasons for a long term study.

girija
girija is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (01-12-2014), Aunt Bean (01-13-2014), lab rat (01-14-2014), olsen (01-12-2014), soccertese (01-12-2014)
Old 01-15-2014, 09:23 PM #10
dilmar's Avatar
dilmar dilmar is offline
Member
 
Join Date: Jan 2009
Posts: 104
15 yr Member
dilmar dilmar is offline
Member
dilmar's Avatar
 
Join Date: Jan 2009
Posts: 104
15 yr Member
Default

http://youtu.be/bK9M2uHt5gk

Trial participant talks of her experience
__________________
"We don't see things as they are, we see them as we are."
Anais Nin.

Last edited by dilmar; 01-15-2014 at 09:50 PM.
dilmar is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (01-16-2014), GerryW (01-15-2014), lab rat (01-16-2014)
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
A noninvasive avenue for Parkinson's disease gene therapy soccertese Parkinson's Disease 0 04-21-2013 01:09 PM
Gene therapy reverses symptoms of Parkinson's disease imark3000 Parkinson's Disease 6 04-15-2011 12:26 AM
DNA nanoparticles hold promise in gene therapy for PD ZucchiniFlower Parkinson's Disease 1 03-01-2007 06:25 PM


All times are GMT -5. The time now is 06:36 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.